Do Mouse Models of Allergic Asthma Mimic Clinical Disease?

International Archives of Allergy and Immunology

Volumn 133, Issue 1, 2004, Pages 84-100

  Epstein, Michelle M ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Airway resistance; Allergens, administration and dosage; Allergic asthma, pathology; Allergic asthma, pathophysiology; Allergic asthma, therapy; Eosinophilic lung inflammation; Immunoglobulin E; Immunological memory; Mice, congenic; Th2 cells

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE;

ALLERGIC ASTHMA; ALLERGY; CLINICAL FEATURE; CLINICAL TRIAL; EOSINOPHIL; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESPIRATORY SYSTEM; REVIEW; SENSITIZATION; WILD TYPE;

ALLERGENS; ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; DISEASE MODELS, ANIMAL; HUMANS; HYPERSENSITIVITY; IMMUNE TOLERANCE; IMMUNIZATION; MICE; PULMONARY EOSINOPHILIA;

EID: 1042286444     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076131     Document Type: Review

References (208)

1. WHO: WHO Fact Sheet Bronchial Asthma. Geneva, World Health Organization, 2000, No 206.
2. Kung TT, Jones H, Adams GR, Umland SP, Kreutner W, Egan RW, Chapman RW, Watnick AS: Characterization of a murine model of allergic pulmonary inflammation. Int Arch Allergy Immunol 1994;105:83-90.
3. Brusselle GG, Kips JC, Tavernier JH, van der Heyden JG, Cuvelier CA, Pauwels RA, Bluethmann H: Attenuation of allergic airway inflammation in IL-4-deficient mice. Clin Exp Allergy 1994;24:73-80.
4. Gavett SH, Chen X, Finkelman F, Wills KM: Depletion of murine CD4+ T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. Am J Respir Cell Mol Biol 1994;10:587-593.
5. Lukacs NW, Strieter RM, Chensue SW, Kunkel SL: Interleukin-4-dependent pulmonary eosinophil infiltration in a murine model of asthma. Am J Respir Cell Mol Biol 1994;10:526-532.
6. Busse WW, Lemanske RF Jr: Asthma. N Engl J Med 2001;344:350-362.
7. Wills-Karp M, Santeliz J, Karp CL: The germless theory of allergic disease: Revisiting the hygiene hypothesis. Nat Rev Immunol 2001;1:69-75.
8. Braun-Fahrlander C: Environmental exposure to endotoxin and other microbial products and the decreased risk of childhood atopy: Evaluating developments since April 2002. Curr Opin Allergy Clin Immunol 2003;3:325-329.
9. Jungsuwadee P, Benkovszky M, Dekan G, Stingl G, Epstein MM: Recurrent aerosol allergen exposure suppresses inflammation in B cell deficient mice with established allergic asthma. Clin Immunol, in press.
10. Mojtabavi N, Dekan G, Stingl G, Epstein MM: Long-lived Th2 memory in experimental allergic asthma. J Immunol 2002;169:4788-4796.
11. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, Donaldson DD: Interleukin-13: Central mediator of allergic asthma. Science 1998;282:2258-2261.
12. Shinagawa K, Kojima M: Mouse model of airway remodeling - Strain differences. Am J Respir Crit Care Med 2003;168:959-967.
13. Yu CK, Shieh CM, Lei HY: Repeated intratracheal inoculation of house dust mite (Dermatophagoides farinae) induces pulmonary eosinophilic inflammation and IgE antibody production in mice. J Allergy Clin Immunol 1999;104:228-236.
14. Graffi SJ, Dekan G, Stingl G, Epstein MM: Systemic administration of antigen-pulsed dendritic cells induces experimental allergic asthma in mice upon aerosol antigen rechallenge. Clin Immunol 2002;103:176-184.
15. Lambrecht BN, Hoogsteden HC, Pauwels RA: Dendritic cells as regulators of the immune response to inhaled allergen: Recent findings in animal models of asthma. Int Arch Allergy Immunol 2001;124:432-446.
16. Lambrecht BN, Pauwels RA, Fazekas De St Groth B: Induction of rapid T cell activation, division, and recirculation by intratracheal injection of dendritic cells in a TCR transgenic model. J Immunol 2000;164:2937-2946.
17. Janssen EM, Wauben MH, Nijkamp FP, van Eden W, van Oosterhout AJ: Immunomodulatory effects of antigen-pulsed macrophages in a murine model of allergic asthma. Am J Respir Cell Mol Biol 2002;27:257-264.
18. Desiqueira A, Russo M, Steil AA, Facincone S, Mariano M, Jancar S: A new murine model of pulmonary eosinophilic hypersensitivity: Contribution to experimental asthma. J Allergy Clin Immunol 1997;100:383-388.
19. Holt PG, Batty JE, Turner KJ: Inhibition of specific IgE responses in mice by pre-exposure to inhaled antigen. Immunology 1981;42:409-417.
20. Sedgwick JD, Holt PG: Down-regulation of immune responses to inhaled antigen: Studies on the mechanism of induced suppression. Immunology 1985;56:635-642.
21. McMenamin C, Holt PG: The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production. J Exp Med 1993;178:889-899.
22. Seymour BW, Gershwin LJ, Coffman RL: Aerosol-induced immunoglobulin (Ig)-E unresponsiveness to ovalbumin does not require CD8+ or T cell receptor (TCR)-gamma/delta+ T cells or interferon (IFN)-gamma in a murine model of allergen sensitization. J Exp Med 1998;187:721-731.
23. Tsitoura DC, Yeung VP, DeKruyff RH, Umetsu DT: Critical role of B cells in the development of T cell tolerance to aeroallergens. Int Immunol 2002;14:659-667.
24. Knott PG, Gater PR, Bertrand CP: Airway inflammation driven by antigen-specific resident lung CD4(+) T cells in alphabeta-T cell receptor transgenic mice. Am J Respir Crit Care Med 2000;161:1340-1348.
25. Wilder JA, Collie DD, Bice DE, Tesfaigzi Y, Lyons CR, Lipscomb MF: Ovalbumin aerosols induce airway hyperreactivity in naive DO11.10 T cell receptor transgenic mice without pulmonary eosinophilia or OVA-specific antibody. J Leukoc Biol 2001;69:538-547.
26. Hogan SP, Koskinen A, Matthaei KI, Young IG, Foster PS: Interleukin-5-producing CD4+ T cells play a pivotal role in aeroallergen- induced eosinophilia, bronchial hyperreactivity, and lung damage in mice. Am J Respir Crit Care Med 1998;157:210-218.
27. Kasai M, Kurasawa K, Nakajima H, Iwamoto I: T cell vaccination eliminates antigen-specific T cells and prevents antigen-induced eosinophil recruitment into the tissue. Int Arch Allergy Immunol 2001;125:59-66.
28. Harris N, Campbell C, Le Gros G, Ronchese F: Blockade of CD28/B7 co-stimulation by mCTLA4-Hgamma1 inhibits antigen-induced lung eosinophilia but not Th2 cell development or recruitment in the lung. Eur J Immunol 1997;27:155-161.
29. Lee SC, Jaffar ZH, Wan KS, Holgate ST, Roberts K: Regulation of pulmonary T cell responses to inhaled antigen: Role in Th1-and Th2-mediated inflammation. J Immunol 1999;162:6867-6879.
30. Cohn L, Homer RJ, Marinov A, Rankin J, Bottomly K: Induction of airway mucus production by T helper 2 (Th2) cells: A critical role for interleukin 4 in cell recruitment but not mucus production. J Exp Med 1997;186:1737-1747.
31. Henderson WR Jr, Chi EY, Maliszewski CR: Soluble IL-4 receptor inhibits airway inflammation following allergen challenge in a mouse model of asthma. J Immunol 2000;164:1086-1095.
32. Jones HP, Hodge LM, Fujihashi K, Kiyono H, McGhee JR, Simecka JW: The pulmonary environment promotes Th2 cell responses after nasal-pulmonary immunization with antigen alone, but Th1 responses are induced during instances of intense immune stimulation. J Immunol 2001;167:4518-4526.
33. Zhang Y, Lamm WJ, Albert RK, Chi EY, Henderson WR Jr, Lewis DB: Influence of the route of allergen administration and genetic background on the murine allergic pulmonary response. Am J Respir Crit Care Med 1997;155:661-669.
34. Jungsuwadee P, Dekan G, Stingl G, Epstein MM: Recurrent aerosol antigen exposure induces distinct patterns of experimental allergic asthma in mice. Clin Immunol 2002;102:145-153.
35. Gavett SH, O'Hearn DJ, Li X, Huang SK, Finkelman FD, Wills KM: Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med 1995;182:1527-1536.
36. Adel-Patient K, Nahori MA, Proust B, Lapa e Silva JR, Creminon C, Wal JM, Vargaftig BB: Elicitation of the allergic reaction in beta-lactoglobulin- sensitized Balb/c mice: Biochemical and clinical manifestations differ according to the structure of the allergen used for challenge. Clin Exp Allergy 2003;33:376-385.
37. Jain VV, Businga TR, Kitagaki K, George CL, O'Shaughnessy PT, Kline JN: Mucosal immunotherapy with CpG oligodeoxynucleotides reverses a murine model of chronic asthma induced by repeated antigen exposure. Am J Physiol Lung Cell Mol Physiol 2003;285:L1137-L1146.
38. Hoshino A, Tanaka Y, Akiba H, Asakura Y, Mita Y, Sakurai T, Takaoka A, Nakaike S, Ishii N, Sugamura K, Yagita H, Okumura K: Critical role for OX40 ligand in the development of pathogenic Th2 cells in a murine model of asthma. Eur J Immunol 2003;33:861-869.
39. Julia V, Hessel EM, Malherbe L, Glaichenhaus N, O'Garra A, Coffman RL: A restricted subset of dendritic cells captures airborne antigens and remains able to activate specific T cells long after antigen exposure. Immunity 2002;16:271-283.
40. Constant SL, Lee KS, Bottomly K: Site of antigen delivery can influence T cell priming: Pulmonary environment promotes preferential Th2-type differentiation. Eur J Immunol 2000;30:840-847.
41. Mehlhop PD, van de Rijn M, Goldberg AB, Brewer JP, Kurup VP, Martin TR, Oettgen HC: Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma. Proc Natl Acad Sci USA 1997;94:1344-1349.
42. Kim J, Merry AC, Nemzek JA, Bolgos GL, Siddiqui J, Remick DG: Eotaxin represents the principal eosinophil chemoattractant in a novel murine asthma model induced by house dust containing cockroach allergens. J Immunol 2001;167:2808-2815.
43. Batanero E, Barral P, Villalba M, Rodriguez R: Sensitization of mice with olive pollen allergen Ole e 1 induces a Th2 response. Int Arch Allergy Immunol 2002;127:269-275.
44. Yu C, Lee S, Wang J, Hsiue T, Lei H: Earlytype hypersensitivity- associated airway inflammation and eosinophilia induced by Dermatophagoides farinae in sensitized mice. J Immunol 1996;156:1923-1930.
45. Bauer L, Bohle B, Jahn SB, Wiedermann U, Daser A, Renz H, Kraft D, Ebner C: Modulation of the allergic immune response in BALB/c mice by subcutaneous injection of high doses of the dominant T cell epitope from the major birch pollen allergen Bet v 1. Clin Exp Immunol 1997;107:536-541.
46. Justice JP, Borchers MT, Lee JJ, Rowan WH, Shibata Y, Van Scott MR: Ragweed-induced expression of GATA-3, IL-4, and IL-5 by eosinophils in the lungs of allergic C57BL/6J mice. Am J Physiol Lung Cell Mol Physiol 2002;282:L302-L309.
47. Cates EC, Gajewska BU, Goncharova S, Alvarez D, Fattouh R, Coyle AJ, Gutierrez-Ramos JC, Jordana M: Effect of GM-CSF on immune, inflammatory, and clinical responses to ragweed in a novel mouse model of mucosal sensitization. J Allergy Clin Immunol 2003;111:1076-1086.
48. O'Brien R, Ooi MA, Clarke AH, Thomas WR: Immunologic responses following respiratory sensitization to house dust mite allergens in mice. Immunol Cell Biol 1996;74:174-179.
49. Cheng KC, Lee KM, Krug MS, Watanabe T, Suzuki M, Choe IS, Yoo TJ: House dust mite-induced sensitivity in mice. J Allergy Clin Immunol 1998;101:1.
50. Ichinose T, Takano H, Sadakane K, Yanagisawa R, Kawazato H, Sagai M, Shibamoto T: Differences in airway-inflammation development by house dust mite and diesel exhaust inhalation among mouse strains. Toxicol Appl Pharmacol 2003;187:29-37.
51. Ichinose T, Takano H, Miyabara Y, Yanagisawa R, Sagai M: Murine strain differences in allergic airway inflammation and immunoglobulin production by a combination of antigen and diesel exhaust particles. Toxicology 1997;122:183-192.
52. Sadakane K, Ichinose T, Takano H, Yanagisawa R, Sagai M, Yoshikawa T, Shibamoto T: Murine strain differences in airway inflammation induced by diesel exhaust particles and house dust mite allergen. Int Arch Allergy Immunol 2002;128:220-228.
53. Tategaki A, Kawamoto S, Okuda T, Aki T, Yasueda H, Suzuki O, Ono K, Shigeta S: A high-molecular-weight mite antigen (HM1) fraction aggravates airway hyperresponsiveness of allergic mice to house dusts and whole mite cultures. Int Arch Allergy Immunol 2002;129:204-211.
54. Valenta R, Kraft D: From allergen structure to new forms of allergen-specific immunotherapy. Curr Opin Immunol 2002;14:718-727.
55. Alkan SS, Akdis AC, Feuerlein D, Gruninger M: Direct measurement of cytokines (IFN-gamma, IL-4, -5, and -6) from organs after antigenic challenge. Ann NY Acad Sci 1996;796:82-90.
56. Holt PG, Rose AH, Batty JE, Turner KJ: Induction of adjuvant-independent IgE responses in inbred mice: Primary, secondary, and persistent IgE responses to ovalbumin and ovomucoid. Int Arch Allergy Appl Immunol 1981;65:42-50.
57. Ormstad H, Groeng EC, Duffort O, Lovik M: The effect of endotoxin on the production of IgE, IgG1 and IgG2a antibodies against the cat allergen Fel d 1 in mice. Toxicology 2003;188:309-318.
58. Eisenbarth SC, Piggott DA, Huleatt JW, Visintin I, Herrick CA, Bottomly K: Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med 2002;196:1645-1651.
59. Dabbagh K, Dahl ME, Stepick-Biek P, Lewis DB: Toll-like receptor 4 is required for optimal development of Th2 immune responses: Role of dendritic cells. J Immunol 2002;168:4524-4530.
60. Tulic MK, Holt PG, Sly PD: Modification of acute and late-phase allergic responses to ovalbumin with lipopolysaccharide. Int Arch Allergy Immunol 2002;129:119-128.
61. Watanabe J, Miyazaki Y, Zimmerman GA, Albertine KH, McIntyre TM: Endotoxin contamination of ovalbumin suppresses murine immunologic responses and development of airway hyper-reactivity. J Biol Chem 2003;278:42361-42368.
62. Gerhold K, Bluemchen K, Franke A, Stock P, Hamelmann E: Exposure to endotoxin and allergen in early life and its effect on allergen sensitization in mice. J Allergy Clin Immunol 2003;112:389-396.
63. Rodriguez D, Keller AC, Faquim-Mauro EL, de Macedo MS, Cunha FQ, Lefort J, Vargaftig BB, Russo M: Bacterial lipopolysaccharide signaling through toll-like receptor 4 suppresses asthma-like responses via nitric oxide synthase 2 activity. J Immunol 2003;171:1001-1008.
64. Suzuki T, Kanoh T, Ishimori M, Ikeda S, Ohkuni H: Adjuvant activity of diesel exhaust particulates (DEP) in production of anti-IgE and anti-IgG1 antibodies to mite allergen in mice. J Clin Lab Immunol 1996;48:187-199.
65. Ormstad H: Suspended particulate matter in indoor air: Adjuvants and allergen carriers. Toxicology 2000;152:53-68.
66. Miyabara Y, Takano H, Ichinose T, Lim HB, Sagai M: Diesel exhaust enhances allergic airway inflammation and hyperresponsiveness in mice. Am J Respir Crit Care Med 1998;157:1138-1144.
67. Seymour B, Pinkerton KE, Friebertshauser KE, Coffman RL, Gershwin LJ: Second-hand smoke is an adjuvant for T helper-2 responses in a murine model of allergy. J Immunol 1997;159:6169-6175.
68. Barrett EG, Wilder JA, March TH, Espindola T, Bice DE: Cigarette smoke-induced airway hyperresponsiveness is not dependent on elevated immunoglobulin and eosinophilic inflammation in a mouse model of allergic airway disease. Am J Respir Crit Care Med 2002;165:1410-1418.
69. Kheradmand F, Kiss A, Xu J, Lee SH, Kolattukudy PE, Corry DB: A protease-activated pathway underlying Th cell type 2 activation and allergic lung disease. J Immunol 2002;169:5904-5911.
70. Garssen J, Vanbree L, Vandervliet H, Vanloveren H: Ozone induced impairment of pulmonary type iv hypersensitivity and airway hyperresponsiveness in mice. Inhal Toxicol 1997;9:581-599.
71. Depuydt PO, Lambrecht BN, Joos GF, Pauwels RA: Effect of ozone exposure on allergic sensitization and airway inflammation induced by dendritic cells. Clin Exp Allergy 2002;32:391-396.
72. Goldsmith CAW, Ning Y, Qin G, Imrich A, Lawrence J, Murthy GGK, Catalano PJ, Kobzik L: Combined air pollution particle and ozone exposure increases airway responsiveness in mice. Inhal Toxicol 2002;14:325-347.
73. Hayashi T, Adachi Y, Hasegawa K, Morimoto M: Less sensitivity for late airway inflammation in males than females in BALB/c mice. Scand J Immunol 2003;57:562-567.
74. Russo M, Jancar S, Pereira de Siqueira AL, Mengel J, Gomes E, Ficker SM, Caetano de Faria AM: Prevention of lung eosinophilic inflammation by oral tolerance. Immunol Lett 1998;61:15-23.
75. Russo M, Nahori MA, Lefort J, Gomes E, de Castro Keller A, Rodriguez D, Ribeiro OG, Adriouch S, Gallois V, de Faria AM, Vargaftig BB: Suppression of asthma-like responses in different mouse strains by oral tolerance. Am J Respir Cell Mol Biol 2001;24:518-526.
76. Wiedermann U, Jahn SB, Fritsch R, Bauer L, Renz H, Kraft D, Ebner C: Effects of adjuvants on the immune response to allergens in a murine model of allergen inhalation: Cholera toxin induces a Th1-like response to Bet v 1, the major birch pollen allergen. Clin Exp Immunol 1998;111:144-151.
77. Lima C, Perini A, Garcia ML, Martins MA, Teixeira MM, Macedo MS: Eosinophilic inflammation and airway hyper-responsiveness are profoundly inhibited by a helminth (Ascaris suum) extract in a murine model of asthma. Clin Exp Allergy 2002;32:1659-1666.
78. Chu HW, Honour JM, Rawlinson CA, Harbeck RJ, Martin RJ: Effects of respiratory Mycoplasma pneumoniae infection on allergen-induced bronchial hyperresponsiveness and lung inflammation in mice. Infect Immun 2003;71:1520-1526.
79. Kips JC, Brusselle GG, Joos GF, Peleman RA, Devos RR, Tavernier JH, Pauwels RA: Importance of interleukin-4 and interleukin-12 in allergen-induced airway changes in mice. Int Arch Allergy Immunol 1995;107:115-118.
80. Hofstra CL, VanArk I, Hofman G, Kool M, Nijkamp FP, VanOosterhout A: Prevention of Th2-like cell responses by coadministration of IL-12 and IL-18 is associated with inhibition of antigen-induced airway hyperresponsiveness, eosinophilia, and serum IgE levels. J Immunol 1998;161:5054-5060.
81. Kuribayashi K, Kodama T, Okamura H, Sugita M, Matsuyama T: Effects of post-inhalation treatment with interleukin-12 on airway hyperreactivity, eosinophilia and interleukin-18 receptor expression in a mouse model of asthma. Clin Exp Allergy 2002;32:641-649.
82. Hayashi T, Maeda K, Hasegawa K, Nakai S, Hamachi T, Iwata H: Systemic administration of interferon-gamma-expressing plasmid reduces late allergic bronchitis in a mouse model of asthma. Int J Exp Pathol 2002;83:81-86.
83. Leonard P, Sur S: Interleukin-12: Potential role in asthma therapy. BioDrugs 2003;17:1-7.
84. Rook GA, Martinelli R, Brunet LR: Innate immune responses to mycobacteria and the downregulation of atopic responses. Curr Opin Allergy Clin Immunol 2003;3:337-342.
85. Erb KJ, Holloway JW, Sobeck A, Moll H, Le Gros G: Infection of mice with Mycobacterium bovis-Bacillus Calmette-Guérin (BCG) suppresses allergen-induced airway eosinophilia. J Exp Med 1998;187:561-569.
86. Hussain I, Kline JN: CpG oligodeoxynucleotides in asthma. Curr Opin Investig Drugs 2001;2:914-918.
87. Jahn-Schmid B, Wiedermann U, Bohle B, Repa A, Kraft D, Ebner C: Oligodeoxynucleotides containing CpG motifs modulate the allergic TH2 response of BALB/c mice to Bet v 1, the major birch pollen allergen. J Allergy Clin Immunol 1999;104:1015-1023.
88. Finotto S, Neurath M, Glickman J, Qin S, Lehr H, Green F, Ackerman K, Haley K, Galle P, Szabo S, Drazen J, DeSanctis G, Glimcher L: Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science 2002;295:336-338.
89. Cross ML, Gill HS: Can immunoregulatory lactic acid bacteria be used as dietary supplements to limit allergies? Int Arch Allergy Immunol 2001;125:112-119.
90. Hansen G, Berry G, DeKruyff RH, Umetsu DT: Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest 1999;103:175-183.
91. Li L, Xia Y, Nguyen A, Feng L, Lo D: Th2-induced eotaxin expression and eosinophilia coexist with Th1 responses at the effector stage of lung inflammation. J Immunol 1998; 161:3128-3135.
92. Randolph DA, Stephens R, Carruthers CJ, Chaplin DD: Cooperation between Th1 and Th2 cells in a murine model of eosinophilic airway inflammation. J Clin Invest 1999;104:1021-1029.
93. Cohn L, Homer RJ, MacLeod H, Mohrs M, Brombacher F, Bottomly K: Th2-induced airway mucus production is dependent on IL-4Ralpha, but not on eosinophils. J Immunol 1999;162:6178-6183.
94. Ferreira MB, da Silva SL, Carlos AG: Atopy and helminths. Allergy Immunol 2002;34:10-12.
95. Akbari O, DeKruyff RH, Umetsu DT: Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2001;2:725-731.
96. Akbari O, Freeman GJ, Meyer EH, Greenfield EA, Chang TT, Sharpe AH, Berry G, DeKruyff RH, Umetsu DT: Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat Med 2002;8:1024-1032.
97. Untersmayr E, Scholl I, Swoboda I, Beil WJ, Forster-Waldl E, Walter F, Riemer A, Kraml G, Kinaciyan T, Spitzauer S, Boltz-Nitulescu G, Scheiner O, Jensen-Jarolim E: Antacid medication inhibits digestion of dietary proteins and causes food allergy: A fish allergy model in BALB/c mice. J Allergy Clin Immunol 2003;112:616-623.
98. Herz U, Braun A, Ruckert R, Renz H: Various immunological phenotypes are associated with increased airway responsiveness. Clin Exp Allergy 1998;28:625-634.
99. Whitehead GS, Walker JK, Berman KG, Foster WM, Schwartz DA: Allergen-induced airway disease is mouse strain dependent. Am J Physiol Lung Cell Mol Physiol 2003;285:L32-L42.
100. De Sanctis G, Merchant M, Beier DR, Dredge RD, Grobholz JK, Martin TR, Lander ES, Drazen JM: Quantitative locus analysis of airway hyperresponsiveness in A/J and C57BL/6J mice. Nat Genet 1995;11:150-154.
101. Kannan MS, Deshpande DA: Allergic asthma in mice: What determines the phenotype? Am J Physiol Lung Cell Mol Physiol 2003;285:L29-L31.
102. Takeda K, Haczku A, Lee JJ, Irvin CG, Gelfand EW: Strain dependence of airway hyperresponsiveness reflects differences in eosinophil localization in the lung. Am J Physiol Lung Cell Mol Physiol 2001;281:L394-L402.
103. Brewer JP, Kisselgof AB, Martin TR: Genetic variability in pulmonary physiological, cellular, and antibody responses to antigen in mice. Am J Respir Crit Care Med 1999;160:1150-1156.
104. Roche WR: Inflammatory and structural changes in the small airways in bronchial asthma. Am J Respir Crit Care Med 1998;157:191S-194S.
105. Drazen JM, Finn PW, De SG: Mouse models of airway responsiveness: Physiological basis of observed outcomes and analysis of selected examples using these outcome indicators. Annu Rev Physiol 1999;61:593-625.
106. Hamelmann E, Schwarze J, Takeda K, Oshiba A, Larsen GL, Irvin CG, Gelfand EW: Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 1997;156:766-775.
107. Lundblad LK, Irvin CG, Adler A, Bates JH: A reevaluation of the validity of unrestrained plethysmography in mice. J Appl Physiol 2002;93:1198-1207.
108. Hantos Z, Brusasco V: Assessment of respiratory mechanics in small animals: The simpler the better? J Appl Physiol 2002;93:1196-1197.
109. Mitzner W, Tankersley C: Interpreting Penh in mice. J Appl Physiol 2003;94:828-831.
110. Irvin CG, Bates JH: Measuring the lung function in the mouse: The challenge of size. Respir Res 2003;4:4.
111. Dohi M, Tsukamoto S, Nagahori T, Shinagawa K, Saitoh K, Tanaka Y, Kobayashi S, Tanaka R, To Y, Yamamoto K: Noninvasive system for evaluating the allergen-specific airway response in a murine model of asthma. Lab Invest 1999;79:1559-1571.
112. Corry DB, Grunig G, Hadeiba H, Kurup VP, Warnock ML, Sheppard D, Rennick DM, Locksley RM: Requirements for allergen-induced airway hyperreactivity in T and B celldeficient mice. Mol Med 1998;4:344-355.
113. Townley RG, Horiba M: Airway hyperresponsiveness: A story of mice and men and cytokines. Clin Rev Allergy Immunol 2003;24:85-110.
114. De Sanctis GT, Itoh A, Green FH, Qin S, Kimura T, Grobholz JK, Martin TR, Maki T, Drazen JM: T-lymphocytes regulate genetically determined airway hyperresponsiveness in mice. Nat Med 1997;3:460-462.
115. Hadeiba H, Corry DB, Locksley RM: Baseline airway hyperreactivity in A/J mice is not mediated by cells of the adaptive immune system. J Immunol 2000;164:4933-4940.
116. De Sanctis GT, Singer JB, Jiao A, Yandava CN, Lee YH, Haynes TC, Lander ES, Beier DR, Drazen JM: Quantitative trait locus mapping of airway responsiveness to chromosomes 6 and 7 in inbred mice. Am J Physiol 1999;277:L1118-L1123.
117. Renz H, Smith HR, Henson JE, Ray BS, Irvin CG, Gelfand EW: Aerosolized antigen exposure without adjuvant causes increased IgE production and increased airway responsiveness in the mouse. J Allergy Clin Immunol 1992;89:1127-1138.
118. Cohn L, Whittaker L, Niu N, Homer RJ: Cytokine regulation of mucus production in a model of allergic asthma. Novartis Found Symp 2002;248:201-213.
119. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, Zhang Y, Elias JA: Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999;103:779-788.
120. Taube C, Duez C, Cui ZH, Takeda K, Rha YH, Park JW, Balhorn A, Donaldson DD, Dakhama A, Gelfand EW: The role of IL-13 in established allergic airway disease. J Immunol 2002;169:6482-6489.
121. Kibe A, Inoue H, Fukuyama S, Machida K, Matsumoto K, Koto H, Ikegami T, Aizawa H, Hara N: Differential regulation by glucocorticoid of interleukin-13-induced eosinophilia, hyperresponsiveness, and goblet cell hyperplasia in mouse airways. Am J Respir Crit Care Med 2003;167:50-56.
122. Herz U, Lumpp U, Daser A, Gelfand EW, Renz H: Murine animal models to study the central role of T cells in immediate-type hypersensitivity responses. Adv Exp Med Biol 1996;409:25-32.
123. Takeda K, Hamelmann E, Joetham A, Shultz LD, Larsen GL, Irvin CG, Gelfand EW: Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice. J Exp Med 1997;186:449-454.
124. Kung T, Stelts D, Zurcher J, Jones H, Umland S, Kreutner W, Egan R, Chapman R: Mast cells modulate allergic pulmonary eosinophilia in mice. Am J Respir Cell Mol Biol 1995;12:404-409.
125. MacLean JA, Sauty A, Luster AD, Drazen JM, De Sanctis GT: Antigen-induced airway hyperresponsiveness, pulmonary eosinophilia, and chemokine expression in B celldeficient mice. Am J Respir Cell Mol Biol 1999;20:379-387.
126. Korsgren M, Erjefalt JS, Korsgren O, Sundler F, Persson CG: Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice. J Exp Med 1997;185:885-892.
127. Hamelmann E, Vella AT, Oshiba A, Kappler JW, Marrack P, Gelfand EW: Allergic airway sensitization induces T cell activation but not airway hyperresponsiveness in B cell-deficient mice. Proc Natl Acad Sci USA 1997;94:1350-1355.
128. Busse WW: Anti-immunoglobulin E (omalizumab) therapy in allergic asthma. Am J Respir Crit Care Med 2001;164:S12-S17.
129. Hsu C, MacGlashan DJ: IgE antibody up-regulates high affinity IgE binding on murine bone marrow-derived mast cells. Immunol Lett 1996;52:129-134.
130. Nagai H, Yamaguchi S, Tanaka H: The role of interleukin-5 (IL-5) in allergic airway hyperresponsiveness in mice. Ann NY Acad Sci 1996;796:91-96.
131. Kobayashi T, Miura T, Haba T, Sato M, Serizawa I, Nagai H, Ishizaka K: An essential role of mast cells in the development of airway hyperresponsiveness in a murine asthma model. J Immunol 2000;164:3855-3861.
132. Yiamouyiannis CA, Schramm CM, Puddington L, Stengel P, Baradaran-Hosseini E, Wolyniec WW, Whiteley HE, Thrall RS: Shifts in lung lymphocyte profiles correlate with the sequential development of acute allergic and chronic tolerant stages in a murine asthma model. Am J Pathol 1999;154:1911-1921.
133. Sakai K, Yokoyama A, Kohno N, Hamada H, Hiwada K: Prolonged antigen exposure ameliorates airway inflammation but not remodeling in a mouse model of bronchial asthma. Int Arch Allergy Immunol 2001;126:126-134.
134. Swirski FK, Sajic D, Robbins CS, Gajewska BU, Jordana M, Stampfli MR: Chronic exposure to innocuous antigen in sensitized mice leads to suppressed airway eosinophilia that is reversed by granulocyte macrophage colony-stimulating factor. J Immunol 2002;169:3499-3506.
135. Hogaboam CM, Blease K, Mehrad B, Steinhauser ML, Standiford TJ, Kunkel SL, Lukacs NW: Chronic airway hyperreactivity, goblet cell hyperplasia, and peribronchial fibrosis during allergic airway disease induced by Aspergillus fumigatus. Am J Pathol 2000;156:723-732.
136. Temelkovski J, Hogan SP, Shepherd DP, Foster PS, Kumar RK: An improved murine model of asthma: Selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax 1998;53:849-856.
137. Trifilieff A, El-Hashim A, Bertrand C: Time course of inflammatory and remodeling events in a murine model of asthma: Effect of steroid treatment. Am J Physiol Lung Cell Mol Physiol 2000;279:L1120-L1128.
138. Kumar RK, Foster PS: Modeling allergic asthma in mice: Pitfalls and opportunities. Am J Respir Cell Mol Biol 2002;27:267-272.
139. Komai M, Tanaka H, Masuda T, Nagao K, Ishizaki M, Sawada M, Nagai H: Role of Th2 responses in the development of allergen-induced airway remodelling in a murine model of allergic asthma. Br J Pharmacol 2003;138:912-920.
140. Holgate ST, Peters-Golden M, Panettieri RA, Henderson WR Jr: Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. J Allergy Clin Immunol 2003;111:S18-S34.
141. Bates CA, Silkoff PE: Exhaled nitric oxide in asthma: From bench to bedside. J Allergy Clin Immunol 2003;111:256-262.
142. De Bie JJ, Hessel EM, Van Ark I, Van Esch B, Hofman G, Nijkamp FP, Van Oosterhout AJ: Effect of dexamethasone and endogenous corticosterone on airway hyperresponsiveness and eosinophilia in the mouse. Br J Pharmacol 1996;119:1484-1490.
143. Blyth DI, Wharton TF, Pedrick MS, Savage TJ, Sanjar S: Airway subepithelial fibrosis in a murine model of atopic asthma: Suppression by dexamethasone or anti-interleukin-5 antibody. Am J Respir Cell Mol Biol 2000;23:241-246.
144. Vanacker NJ, Palmans E, Kips JC, Pauwels RA: Fluticasone inhibits but does not reverse allergen-induced structural airway changes. Am J Respir Crit Care Med 2001;163:674-679.
145. Jeffery P, Godfrey RW, Ädelroth E, Nelson F, Rogers A, Johansson S-Å: Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma: A quantitative light and electron microscopic study. Am Rev Respir Dis 1992;145:890-899.
146. Mathur M, Herrmann K, Li X, Qin Y, Weinstock J, Elliott D, Monahan J, Padrid P: TRFK-5 reverses established airway eosinophilia but not established hyperresponsiveness in a murine model of chronic asthma. Am J Respir Crit Care Med 1999;159:580-587.
147. Jungsuwadee P, Dekan G, Stingl G, Epstein MM: Inhaled dexamethasone differentially attenuates disease relapse and established allergic asthma in mice. Int Arch Allergy Immunol, in press.
148. Garlisi CG, Falcone A, Kung TT, Stelts D, Pennline KJ, Beavis AJ, Smith SR, Egan RW, Umland SP: T cells are necessary for Th2 cytokine production and eosinophil accumulation in airways of antigen-challenged allergic mice. Clin Immunol Immunopathol 1995;75:75-83.
149. Foster PS, Martinez-Moczygemba M, Huston DP, Corry DB: Interleukins-4, -5, and -13: Emerging therapeutic targets in allergic disease. Pharmacol Ther 2002;94:253-264.
150. Wills-Karp M, Chiaramonte M: Interleukin-13 in asthma. Curr Opin Pulm Med 2003;9:21-27.
151. Shimoda K, van Deursen J, Sangster MY, Sarawar SR, Carson RT, Tripp RA, Chu C, Quelle FW, Nosaka T, Vignali DA, Doherty PC, Grosveld G, Paul WE, Ihle JN: Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 1996;380:630-633.
152. Kuperman D, Schofield B, Wills-Karp M, Grusby MJ: Signal transducer and activator of transcription factor 6 (Statb)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production. J Exp Med 1998;187:939-948.
153. Miyata S, Matsuyama T, Kodama T, Nishioka Y, Kuribayashi K, Takeda K, Akira S, Sugita M: STAT6 deficiency in a mouse model of allergen-induced airways inflammation abolishes eosinophilia but induces infiltration of CD8(+) T cells. Clin Exp Allergy 1999;29:114-123.
154. Foster PS, Webb DC, Yang M, Herbert C, Kumar RK: Dissociation of T helper type 2 cytokine-dependent airway lesions from signal transducer and activator of transcription 6 signalling in experimental chronic asthma. Clin Exp Allergy 2003;33:688-695.
155. Das J, Chen CH, Yang L, Cohn L, Ray P, Ray A: A critical role for NF-kappa B in GATA3 expression and TH2 differentiation in allergic airway inflammation. Nat Immunol 2001;2:45-50.
156. Zhang DH, Yang L, Cohn L, Parkyn L, Homer R, Ray P, Ray A: Inhibition of allergic inflammation in a murine model of asthma by expression of a dominant-negative mutant of GATA-3. Immunity 1999;11:473-482.
157. Ray A, Cohn L: Th2 cells and GATA-3 in asthma: New insights into the regulation of airway inflammation. J Clin Invest 1999;104:985-993.
158. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, Corrigan C, Durham SR, Kay AB: Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
159. Li XM, Schofield BH, Wang QF, Kim KH, Huang SK: Induction of pulmonary allergic responses by antigen-specific Th2 cells. J Immunol 1998;160:1378-1384.
160. Coyle AJ, Tsuyuki S, Bertrand C, Huang S, Aguet M, Alkan SS, Anderson GP: Mice lacking the IFN-gamma receptor have impaired ability to resolve a lung eosinophilic inflammatory response associated with a prolonged capacity of T cells to exhibit a Th2 cytokine profile. J Immunol 1996;156:2680-2685.
161. Wilson RA, Coulson PS, Betts C, Dowling MA, Smythies LE: Impaired immunity and altered pulmonary responses in mice with a disrupted interferon-gamma receptor gene exposed to the irradiated Schistosoma mansoni vaccine. Immunology 1996;87:275-282.
162. Henderson WR, Chi EY, Albert RK, Chu SJ, Lamm W, Rochon Y, Jonas M, Christie PE, Harlan JM: Blockade of CD49d (alpha(4) integrin) on intrapulmonary but not circulating leukocytes inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma. J Clin Invest 1997;100:3083-3092.
163. Lobb RR, Abraham WM, Burkly LC, Gill A, Ma W, Knight JA, Leone DR, Antognetti G, Pepinsky RB: Pathophysiologic role of alpha 4 integrins in the lung. Ann NY Acad Sci 1996;796:113-123.
164. Iwamoto I, Nakao A: Induction of Th2 cell tolerance to a soluble antigen by blockade of the LFA-1-dependent pathway prevents allergic inflammation. Immunol Res 1995;14:263-270.
165. Buckley TL, Bloemen PG, Henricks PA, van den Tweel MC, Redegeld FA, Koster AS, Nijkamp FP: LFA-1 and ICAM-1 are crucial for the induction of hyperreactivity in the mouse airways. Ann NY Acad Sci 1996;796:149-161.
166. Lukacs NW, Strieter RM, Chensue SW, Kunkel SL: Activation and regulation of chemokines in allergic airway inflammation. J Leukoc Biol 1996;59:13-17.
167. Wolyniec WW, De Sanctis GT, Nabozny G, Torcellini C, Haynes N, Joetham A, Gelfand EW, Drazen JM, Noonan TC: Reduction of antigen-induced airway hyperreactivity and eosinophilia in ICAM-1-deficient mice. Am J Respir Cell Mol Biol 1998;18:777-785.
168. Borchers MT, Crosby J, Farmer S, Sypek J, Ansay T, Lee NA, Lee JJ: Blockade of CD49d inhibits allergic airway pathologies independent of effects on leukocyte recruitment. Am J Physiol Lung Cell Mol Physiol 2001;280:L813-L821.
169. Keramidaris E, Merson TD, Steeber DA, Tedder TF, Tang ML: L-selectin and intercellular adhesion molecule 1 mediate lymphocyte migration to the inflamed airway/lung during an allergic inflammatory response in an animal model of asthma. J Allergy Clin Immunol 2001;107:734-738.
170. Lee KS, Jin SM, Kim HJ, Lee YC: Matrix metalloproteinase inhibitor regulates inflammatory cell migration by reducing ICAM-1 and VCAM-1 expression in a murine model of toluene diisocyanate-induced asthma. J Allergy Clin Immunol 2003;111:1278-1284.
171. Sheppard D: Functions of pulmonary epithelial integrins: From development to disease. Physiol Rev 2003;83:673-686.
172. Umetsu DT, Akbari O, Dekruyff RH: Regulatory T cells control the development of allergic disease and asthma. J Allergy Clin Immunol 2003;112:480-487.
173. Yssel H, Lecart S, Pene J: Regulatory T cells and allergic asthma. Microbes Infect 2001;3:899-904.
174. Erb KJ, Le Gros G: The role of Th2 type CD4+ T cells and Th2 type CD8+ T cells in asthma. Immunol Cell Biol 1996;74:206-208.
175. Hamelmann E, Oshiba A, Paluh J, Bradley K, Loader J, Potter TA, Larsen GL, Gelfand EW: Requirement for CD8+ T cells in the development of airway hyperresponsiveness in a murine model of airway sensitization. J Exp Med 1996;183:1719-1729.
176. Allakhverdi Z, Lamkhioued B, Olivenstein R, Hamid Q, Renzi PM: CD8 depletion-induced late airway response is characterized by eosinophilia, increased eotaxin, and decreased IFN-gamma expression in rats. Am J Respir Crit Care Med 2000;162:1123-1131.
177. Lisbonne M, Diem S, De Castro Keller A, Lefort J, Araujo LM, Hachem P, Fourneau JM, Sidobre S, Kronenberg M, Taniguchi M, Van Endert P, Dy M, Askenase P, Russo M, Vargaftig BB, Herbelin A, Leite-De-Moraes MC: Cutting edge: Invariant Valpha14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J Immunol 2003;171:1637-1641.
178. Akbari O, Stock P, Meyer E, Kronenberg M, Sidobre S, Nakayama T, Taniguchi M, Grusby MJ, DeKruyff RH, Umetsu DT: Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med 2003;9:582-588.
179. McMenamin C, Pimm C, McKersey M, Holt PG: Regulation of IgE responses to inhaled antigen in mice by antigen-specific gamma delta T cells. Science 1994;265:1869-1871.
180. Zuany-Amorim C, Ruffie C, Haile S, Vargaftig BB, Pereira P, Pretolani M: Requirement for gammadelta T cells in allergic airway inflammation. Science 1998;280:1265-1267.
181. Schramm CM, Puddington L, Yiamouyiannis CA, Lingenheld EG, Whiteley HE, Wolyniec WW, Noonan TC, Thrall RS: Proinflammatory roles of T-cell receptor (TCR)gammadelta and TCRalphabeta lymphocytes in a murine model of asthma. Am J Respir Cell Mol Biol 2000;22:218-225.
182. Cui ZH, Joetham A, Aydintug MK, Hahn YS, Born WK, Gelfand EW: Reversal of allergic airway hyperreactivity after long-term allergen challenge depends on gamma delta T cells. Am J Respir Crit Care Med, in press.
183. Hahn YS, Taube C, Jin N, Takeda K, Park JW, Wands JM, Aydintug MK, Roark CL, Lahn M, O'Brien RL, Gelfand EW, Born WK: V gamma4+ gamma delta T cells regulate airway hyperreactivity to methacholine in ovalbumin-sensitized and challenged mice. J Immunol 2003;171:3170-3178.
184. Schon HM, Oliver J, McMenamin PG, Holt PG: Studies on the density, distribution, and surface phenotype of intraepithelial class II major histocompatibility complex antigen (Ia)-bearing dendritic cells (DC) in the conducting airways. J Exp Med 1991;173:1345-1356.
185. Holt PG, Stumbles PA: Regulation of immunologic homeostasis in peripheral tissues by dendritic cells: The respiratory tract as a paradigm. J Allergy Clin Immunol 2000;105:421-429.
186. Holt PG, Stumbles PA: Characterization of dendritic cell populations in the respiratory tract. J Aerosol Med 2000;13:361-367.
187. McWilliam AS, Nelson DJ, Holt PG: The biology of airway dendritic cells. Immunol Cell Biol 1995;73:405-413.
188. Vermaelen KY, Pauwels RA: Accelerated airway dendritic cell maturation, trafficking and elimination in a mouse model of asthma. Am J Respir Cell Mol Biol 2003;29:405-409.
189. Cheng X, Wang C, Qian G, Zhu B: CD80, but not CD86 were up-regulated on the spleenderived dendritic cells from OVA-sensitized and challenged BALB/c mice. Immunol Lett 2003;89:31-38.
190. Upham JW, Stumbles PA: Why are dendritic cells important in allergic diseases of the respiratory tract? Pharmacol Ther 2003;100:75-87.
191. Stumbles PA, Strickland DH, Pimm CL, Proksch SF, Marsh AM, McWilliam AS, Bosco A, Tobagus I, Thomas JA, Napoli S, Proudfoot AE, Wells TN, Holt PG: Regulation of dendritic cell recruitment into resting and inflamed airway epithelium: Use of alternative chemokine receptors as a function of inducing stimulus. J Immunol 2001;167:228-234.
192. Huh JC, Strickland DH, Jahnsen FL, Turner DJ, Thomas JA, Napoli S, Tobagus I, Stumbles PA, Sly PD, Holt PG: Bidirectional interactions between antigen-bearing respiratory tract dendritic cells (DCs) and T cells precede the late phase reaction in experimental asthma: DC activation occurs in the airway mucosa but not in the lung parenchyma. J Exp Med 2003;198:19-30.
193. Stumbles PA, Upham JW, Holt PG: Airway dendritic cells: Co-ordinators of immunological homeostasis and immunity in the respiratory tract. APMIS 2003;111:741-755.
194. Lambrecht BN, Salomon B, Klatzmann D, Pauwels RA: Dendritic cells are required for the development of chronic eosinophilic airway inflammation in response to inhaled antigen in sensitized mice. J Immunol 1998;160:4090-4097.
195. Lambrecht BN, De Veerman M, Coyle AJ, Gutierrez Ramos JC, Thielemans K, Pauwels RA: Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation. J Clin Invest 2000;106:551-559.
196. Schipf A, Heilmann A, Boue L, Mossmann H, Brocker T, Rocken M: Th2 cells shape the differentiation of developing T cell responses during interactions with dendritic cells in vivo. Eur J Immunol 2003;33:1697-1706.
197. Stumbles PA, Thomas JA, Pimm CL, Lee PT, Venaille TJ, Proksch S, Holt PG: Resting respiratory tract dendritic cells preferentially stimulate T helper cell type 2 (Th2) responses and require obligatory cytokine signals for induction of Th1 immunity. J Exp Med 1998;188:2019-2031.
198. Stumbles PA: Regulation of T helper cell differentiation by respiratory tract dendritic cells. Immunol Cell Biol 1999;77:428-433.
199. van Rijt LS, Lambrecht BN: Role of dendritic cells and Th2 lymphocytes in asthma: Lessons from eosinophilic airway inflammation in the mouse. Microsc Res Tech 2001;53:256-272.
200. Holt PG, Haining S, Nelson DJ, Sedgwick JD: Origin and steady-state turnover of class II MHC-bearing dendritic cells in the epithelium of the conducting airways. J Immunol 1994;153:256-261.
201. Tang C, Inman MD, van Rooijen N, Yang P, Shen H, Matsumoto K, O'Byrne PM: Th type 1-stimulating activity of lung macrophages inhibits Th2-mediated allergic airway inflammation by an IFN-gamma-dependent mechanism. J Immunol 2001;166:1471-1481.
202. Pynaert G, Rottiers P, Haegeman A, Sehra S, Korf J, Grooten J: Antigen presentation by local macrophages promotes nonallergic airway responses in sensitized mice. Am J Respir Cell Mol Biol 2003;29:634-641.
203. Damiani G: The role of macrophages and lymphocytes in bronchial asthma: Perspectives for new research models. Eur Respir J Suppl 1989;6:469s-472s.
204. Holt PG, Degebrodt A, O'Leary C, Krska K, Plozza T: T cell activation by antigen-presenting cells from lung tissue digests: Suppression by endogenous macrophages. Clin Exp Immunol 1985;62:586-593.
205. Thepen T, McMenamin C, Oliver J, Kraal G, Holt PG: Regulation of immune response to inhaled antigen by alveolar macrophages: Differential effects of in vivo alveolar macrophage elimination on the induction of tolerance vs. immunity. Eur J Immunol 1991;21:2845-2850.
206. Bilyk N, Holt PG: Cytokine modulation of the immunosuppressive phenotype of pulmonary alveolar macrophage populations. Immunology 1995;86:231-237.
207. Kuchroo VK, Umetsu DT, DeKruyff RH, Freeman GJ: The TIM gene family: Emerging roles in immunity and disease. Nat Rev Immunol 2003;3:454-462.
208. Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B, Gilliet M, Ho S, Antonenko S, Lauerma A, Smith K, Gorman D, Zurawski S, Abrams J, Menon S, McClanahan T, de Waal-Malefyt Rd R, Bazan F, Kastelein RA, Liu YJ: Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 2002;3:673-680.